RIPK1 is dispensable for cell death regulation in β-cells during hyperglycemia
Objective: Receptor-interacting protein kinase 1 (RIPK1) orchestrates the decision between cell survival and cell death in response to tumor necrosis factor (TNF) and other cytokines. Whereas the scaffolding function of RIPK1 is crucial to prevent TNF-induced apoptosis and necroptosis, its kinase ac...
Saved in:
Main Authors: | Önay Veli (Author), Öykü Kaya (Author), Ana Beatriz Varanda (Author), Ximena Hildebrandt (Author), Peng Xiao (Author), Yann Estornes (Author), Matea Poggenberg (Author), Yuan Wang (Author), Manolis Pasparakis (Author), Mathieu J.M. Bertrand (Author), Henning Walczak (Author), Alessandro Annibaldi (Author), Alessandra K. Cardozo (Author), Nieves Peltzer (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inhibition of RIPK1 kinase does not affect diabetes development: β-Cells survive RIPK1 activation
by: Tatiana Takiishi, et al.
Published: (2023) -
RIPK1 and RIPK3 regulate TNFα-induced β-cell death in concert with caspase activity
by: Christopher J. Contreras, et al.
Published: (2022) -
Cell-specific and athero-protective roles for RIPK3 in a murine model of atherosclerosis
by: Sarah Colijn, et al.
Published: (2020) -
RIPK3‐mediated cell death is involved in DUX4‐mediated toxicity in facioscapulohumeral dystrophy
by: Virginie Mariot, et al.
Published: (2021) -
Advances in RIPK1 kinase inhibitors
by: Lu Chen, et al.
Published: (2022)